FDA Opens Comment Period on GenAI Device Regulation - Medical Device and Diagnostic industry
Reported by Medical Device and Diagnostic industry · all stories from mddionline.com
Editorial digest
The U.S. Food and Drug Administration has opened a period for public comments regarding the regulation of generative artificial intelligence in medical devices.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at Medical Device and Diagnostic industry →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom11/3/2026
STAT+: FDA, CMS look to collaborate with states on health AI
Federal regulators at the FDA and CMS plan to partner with state authorities regarding medical artificial intelligence.
- Trusted health newsroom10/30/2026
STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
Federal health agencies are working quickly to prevent oversight bottlenecks as states prepare clinical artificial intelligence trials.
- Trusted health newsroom10/22/2026
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Federal regulators have completed formal guidelines for software applications paired with medications, drawing positive reactions from pharmaceutical manufacturers.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.
- Trusted health newsroom11/12/2026
STAT+: New documents raise more questions about Medicare’s AI prior-authorization experiment
Newly surfaced records prompt growing scrutiny regarding Medicare's pilot initiative using artificial intelligence for coverage approvals.
- Trusted health newsroom11/6/2026
STAT+: After Medicare punts RPM overhaul to 2029, advocates see window to fight back
Advocates plan to challenge Medicare's remote monitoring overhaul after officials postponed the policy update to 2029.
